This company has been acquired
NTUS Stock Overview
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Natus Medical Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$32.96 |
| 52 Week High | US$33.93 |
| 52 Week Low | US$20.90 |
| Beta | 0.23 |
| 1 Month Change | 2.08% |
| 3 Month Change | -1.38% |
| 1 Year Change | 34.37% |
| 3 Year Change | 23.22% |
| 5 Year Change | -8.06% |
| Change since IPO | 128.10% |
Recent News & Updates
Recent updates
Novanta to replace Six Flags Entertainment in S&P MidCap 400, Six Flags to replace Natus Medical in S&P SmallCap 600
Jul 22Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital
Mar 04
Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital
Nov 08We Like Natus Medical's (NASDAQ:NTUS) Earnings For More Than Just Statutory Profit
Aug 13Does Natus Medical (NASDAQ:NTUS) Have A Healthy Balance Sheet?
Aug 02We Think Shareholders Are Less Likely To Approve A Pay Rise For Natus Medical Incorporated's (NASDAQ:NTUS) CEO For Now
Jun 10Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)
May 05Is Natus Medical (NASDAQ:NTUS) Using Debt Sensibly?
Feb 15
Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)
Jan 11Reflecting on Natus Medical's (NASDAQ:NTUS) Share Price Returns Over The Last Five Years
Dec 07Shareholder Returns
| NTUS | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0.8% | 1.6% | 0.7% |
| 1Y | 34.4% | 9.2% | 23.9% |
Return vs Industry: NTUS exceeded the US Medical Equipment industry which returned -23.9% over the past year.
Return vs Market: NTUS exceeded the US Market which returned -15.4% over the past year.
Price Volatility
| NTUS volatility | |
|---|---|
| NTUS Average Weekly Movement | 2.2% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 18.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NTUS has not had significant price volatility in the past 3 months.
Volatility Over Time: NTUS's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 1,400 | Tom Sullivan | www.natus.com |
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories.
Natus Medical Incorporated Fundamentals Summary
| NTUS fundamental statistics | |
|---|---|
| Market cap | US$1.13b |
| Earnings (TTM) | US$12.68m |
| Revenue (TTM) | US$478.30m |
89.0x
P/E Ratio2.4x
P/S RatioIs NTUS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NTUS income statement (TTM) | |
|---|---|
| Revenue | US$478.30m |
| Cost of Revenue | US$199.61m |
| Gross Profit | US$278.70m |
| Other Expenses | US$266.01m |
| Earnings | US$12.68m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.37 |
| Gross Margin | 58.27% |
| Net Profit Margin | 2.65% |
| Debt/Equity Ratio | 0% |
How did NTUS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/07/22 08:34 |
| End of Day Share Price | 2022/07/20 00:00 |
| Earnings | 2022/03/31 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Natus Medical Incorporated is covered by 14 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daniel Owczarski | Avondale Partners |
| Raymond Myers | Benchmark Company |
| Lawrence Solow | CJS Securities, Inc. |